Call for information/EOI for neutralising antibodies.
key details
| Value | £1 |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 |
| OCID | ocds-h6vhtk-02e853 |
description
DHSC invites suppliers to submit an EOI on neutralising antibodies andbinding site, clinical trials on efficacy, safetyfor preventing or treating COVID-19infection, dose&frequency, formats/routesfor administering to patients, monitoringadverse affects, efficacy against SARSCoV-2 variants, supply availability for 2021-2022 and future years and plans forregulatory approval in the UK, if not yetapproved.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 5 Oct 2021 | Prior information notice (F01) | Earlier regulations | 024806-2021 |
| 9 Dec 2021 | Planning (planning) | · | b16a9c81-97ef-4281-8a4f-5486929f4621-492960 |
| 10 Dec 2021 | Corrigendum (F14) | Earlier regulations | 030768-2021 |
more from Department of Health and Social Care
- DHSC Sinogo claim legal support · £100,000 · 22 Jul 2026
- National Institute for Health and Care Research (NIHR) pre-action letter advice · £80,000 · 22 Jul 2026
- DHSC: ASC: Waves 3 – 5 of the Adult Social Care Workforce Employee Survey · 15 Jul 2026
- Hugh's Report - MH Impact of Life-Threatening Child Illness on Families 2026 · 26 Jun 2026
- Library Mgmt and Enquiry System, E-Archive · £22,578 · 22 Jun 2026
- DHSC: Leeds Maternity Review legal services · £432,000 · 22 Jun 2026
- DHSC:TDD: Technology, Digital and Data (TDD) Operating Model Sprint · £790,000 · 19 Jun 2026
- DHSC: TD: HDRS Corporate technical specialist data services MR · £250,000 · 16 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.